Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones
Authors:
- Yusuke OnikiYOYusuke Oniki
- Tamaki KatoTKTamaki Kato
- Norikazu NishinoNNNorikazu Nishino
- Yuko SumidaYSYuko Sumida
- Minoru YoshidaMYMinoru Yoshida
- 1 November 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (21) , 5343-5346
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligandBioorganic & Medicinal Chemistry Letters, 2004
- Cyclic Tetrapeptides Bearing a Sulfhydryl Group Potently Inhibit Histone DeacetylasesOrganic Letters, 2003
- From Discovery to the Coming Generation of Histone Deacetylase InhibitorsCurrent Medicinal Chemistry, 2003
- Histone Deacetylase InhibitorsJournal of Medicinal Chemistry, 2003
- Deacetylase EnzymesChemistry & Biology, 2002
- Histone deacetylase inhibitors as new cancer drugsCurrent Opinion in Oncology, 2001
- Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitorsExpert Opinion on Investigational Drugs, 2000
- Synthesis and Histone Deacetylase Inhibitory Activity of New Benzamide DerivativesJournal of Medicinal Chemistry, 1999
- Histone acetylases and deacetylases in cell proliferationCurrent Opinion in Genetics & Development, 1999
- Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACsCurrent Opinion in Chemical Biology, 1997